§ Funding Round
Series B funding round for Quell Therapeutics raising $160M in November 2021
Series B funding round for Quell Therapeutics raising $160M in November 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
| Organization | — | |
SV Health Investors | — | — |
| Angel | judith hartley mbe | |
Fidelity Management & Research CompanyLEAD | — | — |
Janus Henderson Investors | — | — |
rachel mearsLEAD | Angel | rachel mears |
| Organization | — | |
Point72 | — | — |
wayne holmanLEAD | Angel | wayne holman |
houman ashrafianLEAD | Angel | houman ashrafian |
| Angel | martin murphy | |
| Organization | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$204.6M
Top Valuation
-
Quell Therapeutics raised $160M in a Series B round.
The round was announced on 11/01/21.
The round was led by Fidelity Management & Research Company, rachel mears, wayne holman, houman ashrafian.
